Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140608 · ClinicalTrials.gov registry record · NA
Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery
A NA study, sponsored by Genzyme, a Sanofi Company.
- Terminated
- Registry status
- NA
- Development phase
NCT00140608: Clinical Trial NA study, sponsored by Genzyme, a Sanofi Company.
NCT00140608 is a NA study that was terminated before completion, run by Genzyme, a Sanofi Company. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00140608, a NA study, was terminated before completion, sponsored by Genzyme, a Sanofi Company.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to investigate if the space occupying effect of Seprapack will lead to a reduction in post operative adhesions and more healing of the sinus cavity when compared to the use of no packing material.
Interventions
- DEVICE Seprapack Sinus Dressing
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-06 |
| Est. Completion | 2005-05 |
| Phase | NA |
Why NCT00140608 stopped before completion
NCT00140608 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Seprapack Sinus Dressing is the first listed.
NCT00140608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00140608 about?
NCT00140608 is a clinical study titled "Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery". The purpose of this study is to investigate if the space occupying effect of Seprapack will lead to a reduction in post operative adhesions and more healing of the sinus cavity when compared to the use of no packing material.
What is the current status of trial NCT00140608?
This trial is currently terminated. It is a NA study. The study started on 2003-06. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00140608?
The interventions under investigation include: Seprapack Sinus Dressing (DEVICE).
Who is sponsoring clinical trial NCT00140608?
This trial is sponsored by Genzyme, a Sanofi Company, which has 196 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia